Appropriateness of TAVR Across the Spectrum of Surgical Risk

Release Date: Oct 21, 2019

Expired Date: Oct 21, 2020

 

This activity is intended for cardiovascular adult physicians, cardiac surgeons, and family physicians.

 

• 0.25 CME Credit

• 0.25 MOC Credit

 

This activity was planned with a goal to describe transcatheter aortic valve replacement (TAVR) outcomes in low- risk patients as compared to standard surgical AVR, as well as key limitations to the current studies.

 

Upon completion of this program, you should be able to discuss the safety and efficacy of transcatheter aortic valve replacement (TAVR) compared to surgical AVR (SAVR) in low surgical risk patients.